COVID-19 vaccine safety and side effects in children aged 5-11 years: a cross-sectional study

M A Nurhani1, H M S Farah1, N M A Ili1

  • 1Hospital Tuanku Ja'afar, Jalan Rasah, Seremban, Negeri Sembilan, Ministry of Health Malaysia.

PubMed

Insights

The Pfizer-BioNTech COVID-19 vaccine showed good tolerability in children, with most side effects being mild and short-lived. This supports vaccine safety for pediatric populations, including those with co-morbidities.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health

Background:

  • The COVID-19 pandemic necessitated rapid vaccine development and deployment, including for pediatric populations.
  • Assessing the safety and tolerability of vaccines in children is critical for public trust and informed decision-making.
  • The Pfizer-BioNTech (BNT162b2) vaccine is a key tool in global vaccination efforts.

Purpose of the Study:

  • To evaluate the safety and side effect profile of the Pfizer-BioNTech (BNT162b2) vaccine in children.
  • To determine the proportion of children experiencing postvaccination side effects.
  • To identify factors associated with the occurrence of side effects in pediatric vaccine recipients.

Main Methods:

  • A cross-sectional study design was employed.
  • Data were collected from 195 children vaccinated between February 3 and May 8, 2022.
  • Parent or legal guardian completed self-administered questionnaires regarding side effects.

Main Results:

  • 31.8% of vaccinated children reported side effects, most commonly injection site pain (29.7%), fever (15.9%), and localized inflammation (10.8%).
  • No severe adverse events like anaphylaxis or myocarditis were reported.
  • Children with underlying co-morbidities showed a higher proportion of side effects; no significant differences were noted based on age, weight, allergies, or premedication.

Conclusions:

  • The BNT162b2 vaccine demonstrated good tolerability in the pediatric population studied.
  • Reported side effects were predominantly mild and self-limiting.
  • Findings support the safety of COVID-19 vaccination in children and inform healthcare providers, parents, and policymakers, particularly for high-risk groups.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
850
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
419
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
847